Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick Skinner

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Plos One|January 10, 2013
Follow-up programs for childhood cancer survivors in Europe: a questionnaire surveyStefan Essig, Roderick Skinner, Nicolas X von der Weid, et al.
Pediatric Blood & Cancer|April 21, 2010
Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or doseRoderick Skinner, Annie Parry, Lisa Price, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2009
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factorsRoderick Skinner, Annie Parry, Lisa Price, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2016
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patientsVictoria J Forster, Frederik W van Delft, Susan F Baird, et al.
Pediatric Clinics of North America|November 2, 2020
The Critical Role of Clinical Practice Guidelines and Indicators in High-Quality Survivorship After Childhood CancerRenée L Mulder, Rebecca J van Kalsbeek, Melissa M Hudson, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 24, 2012
Central nervous system lesions in Malawian children: identifying the treatableDipayan Mitra, Sam Kampondeni, Mac Mallewa, et al.
Annals of Hematology|September 19, 2014
Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemiaHeidrun Boztug, Marco Zecca, Karl-Walter Sykora, et al.
BMJ Open|December 29, 2020
Using qualitative and co-design methods to inform the development of an intervention to support and improve physical activity in childhood cancer survivors: a study protocol for BEing Active after ChildhOod caNcer (BEACON)Morven C Brown, Vera Araújo-Soares, Roderick Skinner, et al.
JAMA|July 15, 2010
Long-term cause-specific mortality among survivors of childhood cancerRaoul C Reulen, David L Winter, Clare Frobisher, et al.
Plos One|May 15, 2024
Protocol for the 'Supporting Young Cancer Survivors who Smoke' study (PRISM): Informing the development of a smoking cessation intervention for childhood, adolescent and young adult cancer survivors in EnglandMorven C Brown, Vera Araújo-Soares, Roderick Skinner, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Plos One|January 10, 2013
Follow-up programs for childhood cancer survivors in Europe: a questionnaire surveyStefan Essig, Roderick Skinner, Nicolas X von der Weid, et al.
Pediatric Blood & Cancer|April 21, 2010
Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or doseRoderick Skinner, Annie Parry, Lisa Price, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2009
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factorsRoderick Skinner, Annie Parry, Lisa Price, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2016
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patientsVictoria J Forster, Frederik W van Delft, Susan F Baird, et al.
Pediatric Clinics of North America|November 2, 2020
The Critical Role of Clinical Practice Guidelines and Indicators in High-Quality Survivorship After Childhood CancerRenée L Mulder, Rebecca J van Kalsbeek, Melissa M Hudson, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 24, 2012
Central nervous system lesions in Malawian children: identifying the treatableDipayan Mitra, Sam Kampondeni, Mac Mallewa, et al.
Annals of Hematology|September 19, 2014
Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemiaHeidrun Boztug, Marco Zecca, Karl-Walter Sykora, et al.
BMJ Open|December 29, 2020
Using qualitative and co-design methods to inform the development of an intervention to support and improve physical activity in childhood cancer survivors: a study protocol for BEing Active after ChildhOod caNcer (BEACON)Morven C Brown, Vera Araújo-Soares, Roderick Skinner, et al.
JAMA|July 15, 2010
Long-term cause-specific mortality among survivors of childhood cancerRaoul C Reulen, David L Winter, Clare Frobisher, et al.
Plos One|May 15, 2024
Protocol for the 'Supporting Young Cancer Survivors who Smoke' study (PRISM): Informing the development of a smoking cessation intervention for childhood, adolescent and young adult cancer survivors in EnglandMorven C Brown, Vera Araújo-Soares, Roderick Skinner, et al.
Pageof 13